Please login to the form below
celecoxib
This page shows the latest celecoxib news and features for those working in and with pharma, biotech and healthcare.
Products over pipeline in Pfizer's acquisition targets, hints CEO
Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex (celecoxib) last December in the US, with competition already being felt
Latest news
-
Pfizer 2014 guidance threatened by Celebrex competition
courts. Several generic pharma companies have been planning to launch copycat versions of Celebrex (celecoxib) in the US on May 30, when the basic patent on the active ingredient of the
-
Pfizer sales down but oncology shows promise
There were also gains for anti-inflammatory Celebrex (celecoxib), up 11 per cent to $752m, while fibromyalgia drug Lyrica (pregabalin) cemented its position as Pfizer's biggest-selling product with a
-
Pfizer sales dip as net income surges in Q2
Epilepsy, neuropathic pain and fibromyalgia therapy Lyrica (pregabalin) cemented its position as Pfizer's biggest product with a 10 per cent gain to $1.13bn, while painkiller Celebrex (celecoxib) grew 10
-
GSK fires senior Chinese scientist over data fabrication
to faking dozens of research studies, including trials of Pfizer's Celebrex (celecoxib) and Merck &Co's Vioxx (rofecoxib).
-
Pfizer sues as Celebrex patent is reissued in US
Celebrex (celecoxib) remains a major product for Pfizer, with global sales growing 9 per cent to $2.7bn last year, mainly as a treatment for osteoarthritis. ... We are pleased with the reissuance of this patent protecting the invention of using celecoxib
More from news
Approximately 3 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Immunocore names CEO
During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Associate Director
-
£75, 000-90, 000
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Systematic Reviewer - Oxford
-
Negotiable
-
Account Manager
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Business Development Director – Health Education
-
excellent commission
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
- Account Manager- Healthcare Advertising
-
Negotiable
-
Senior Account Manager
-
Competitive Salary Offered
Subscribe to our email news alerts
- Fishawack acquires Blue Latitude Health
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
- Axovant drops last ‘legacy’ drug to focus on gene therapies
- Healthcare excellence celebrated at 2018 HSJ Awards
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
